Issue Archive
December 2007 | Volume 6 | Issue 12
Original Articles
Issues Affecting Specialty Career Paths in Dermatology
As the field of medicine changes, physicians deal with ever-increasing challenges and pressures. An overview of broad career paths within the specialty of dermatology is presented and important issue...
Read MorePulsed Dye Laser for the Treatment of Hypergranulation Tissue with Chronic Ulcer in Postsurgical Defects
Background and Objective: Hypergranulation tissue may complicate postoperative wounds, causing them to become chronic nonhealing ulcers. There is no reliably effective treatment. We report the use of...
Read MoreTopical Photodynamic Therapy for Dermatologic Disorders: Results and Complications
Background: Topical photodynamic therapy (PDT) involves the use of a photosensitizing topical medication that is activated by a light source in the presence of oxygen leading to cellular destruction ...
Read MoreDuration of Remission of Biologic Agents for Chronic Plaque Psoriasis
Background: The efficacy of biologic agents to treat psoriasis has been established in well-designed clinical trials. The primary endpoint is usually a 75% reduction from the baseline Psoriasis Area ...
Read MorePyoderma Gangrenosum: Dermatologic Application of Hyperbaric Oxygen Therapy
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis of skin and subcutaneous tissue. The current accepted theory is that PG is an immunologic-based phenomenon. Several therapies have been use...
Read More
Features
Case Reports
New Onset Flushing due to Unauthorized Substitution of Niacin for Nicotinamide
Nicotinamide is the amide form of niacin and has anti-inflammatory properties that have led to its use in the treatment of several inflammatory dermatologic conditions, such as rosacea. Niacin has es...
Read MoreType I Hypersensitivity to Lidocaine
Lidocaine hydrochloride is the most commonly used anesthetic agent in dermatology. Despite its widespread and frequent use, adverse reactions to lidocaine are uncommon. The majority of side effects i...
Read MorePractical Experience with Efalizumab in Hand and Foot Psoriasis
Psoriasis of the hands and feet is highly debilitating and difficult to treat. It may be of a plaque-or pustular-type, or a combination of the two. Efalizumab (Raptiva®, Genentech Inc), a humanize...
Read MoreMinocycline-Induced Hyperpigmentation Resolves during Oral Isotretinoin Therapy
Although disfiguring hyperpigmentation is a well-defined complication of minocycline therapy, modalities to reverse the phenomenon are unpredictable. We report a case of minocycline-induced, blue-bla...
Read More
